Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics


Ironwood Pharmaceuticals, Inc. - (IRWD): $11.72

0.36 (+3.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IRWD POWR Grades


  • IRWD scores best on the Value dimension, with a Value rank ahead of 97.58% of US stocks.
  • IRWD's strongest trending metric is Growth; it's been moving down over the last 157 days.
  • IRWD's current lowest rank is in the Momentum metric (where it is better than 9.43% of US stocks).

IRWD Stock Summary

  • IRWD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 5.79 -- higher than 25.13% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 3.62, Ironwood Pharmaceuticals Inc P/E ratio is greater than that of about merely 3.17% of stocks in our set with positive earnings.
  • The volatility of Ironwood Pharmaceuticals Inc's share price is greater than that of 27.87% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to IRWD, based on their financial statements, market capitalization, and price volatility, are PTE, NBIX, GTYH, AFIB, and KTOS.
  • Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

  • In comparison to the median Healthcare stock, IRWD's price/sales ratio is 36.84% higher, now standing at 5.2.
  • Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.
  • Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.

Below are key valuation metrics over time for IRWD.

Stock Date P/S P/B P/E EV/EBIT
IRWD 2021-08-31 5.2 4.2 4.2 10.3
IRWD 2021-08-30 5.2 4.2 4.3 10.4
IRWD 2021-08-27 5.2 4.2 4.2 10.4
IRWD 2021-08-26 5.2 4.2 4.2 10.3
IRWD 2021-08-25 5.2 4.2 4.2 10.3
IRWD 2021-08-24 5.2 4.2 4.2 10.4

IRWD Growth Metrics

    The 3 year cash and equivalents growth rate now stands at -57.26%.
  • Its 4 year net cashflow from operations growth rate is now at 236.25%.
  • Its 5 year cash and equivalents growth rate is now at -17.42%.
Over the past 33 months, IRWD's revenue has gone up $66,664,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 413.303 248.84 530.278
2021-06-30 413.024 227.407 508.856
2021-03-31 398.425 198.927 142.757
2020-12-31 389.523 168.836 106.176
2020-09-30 399.144 144.903 110.83
2020-06-30 426.843 126.038 97.055

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
  • IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
  • LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.998 0.305
2021-03-31 0.761 0.998 0.286
2020-12-31 0.820 0.992 0.226
2020-09-30 0.916 0.967 0.230
2020-06-30 1.077 0.976 0.213
2020-03-31 1.207 0.951 0.198

IRWD Price Target

For more insight on analysts targets of IRWD, see our IRWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.83 Average Broker Recommendation 1.71 (Moderate Buy)

IRWD Stock Price Chart Interactive Chart >

Price chart for IRWD

IRWD Price/Volume Stats

Current price $11.72 52-week high $14.27
Prev. close $11.36 52-week low $8.78
Day low $11.24 Volume 1,850,900
Day high $11.74 Avg. volume 1,860,030
50-day MA $11.67 Dividend yield N/A
200-day MA $12.20 Market Cap 1.92B

Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio


Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.


IRWD Latest News Stream


Event/Time News Detail
Loading, please wait...

IRWD Latest Social Stream


Loading social stream, please wait...

View Full IRWD Social Stream

Latest IRWD News From Around the Web

Below are the latest news stories about Ironwood Pharmaceuticals Inc that investors may wish to consider to help them evaluate IRWD as an investment opportunity.

Ironwood Pharmaceuticals (IRWD) presents at JP Morgan 40th Annual Virtual Healthcare Conference (Slideshow)

The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 14, 2022

Top Pharmaceutical Stocks for Q1 2022

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2022.

Yahoo | January 13, 2022

Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance

BOSTON, January 10, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided updated financial guidance for full year 2021 and announced financial guidance for full year 2022. The results were announced in advance of the Company’s presentation at the 40th Annual J.P. Morgan Healthcare Conference, which will take place on Wednesday, January 12, 2022 at 7:30 a.m. ET.

Yahoo | January 10, 2022

Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

BOSTON, January 05, 2022--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. ET.

Yahoo | January 5, 2022

Putnam Variable Trust Buys Intuit Inc, Bank of America Corp, Advanced Micro Devices Inc, Sells ...

Investment company Putnam Variable Trust (Current Portfolio) buys Intuit Inc, Bank of America Corp, Advanced Micro Devices Inc, O'Reilly Automotive Inc, T-Mobile US Inc, sells Applied Materials Inc, Activision Blizzard Inc, NXP Semiconductors NV, Dollar General Corp, Berkshire Hathaway Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Putnam Variable Trust.

Yahoo | December 24, 2021

Read More 'IRWD' Stories Here

IRWD Price Returns

1-mo 4.18%
3-mo -12.21%
6-mo -9.78%
1-year N/A
3-year -9.22%
5-year -20.60%
YTD 0.51%
2021 2.37%
2020 -14.43%
2019 28.47%
2018 -30.89%
2017 -1.96%

Continue Researching IRWD

Here are a few links from around the web to help you further your research on Ironwood Pharmaceuticals Inc's stock as an investment opportunity:

Ironwood Pharmaceuticals Inc (IRWD) Stock Price | Nasdaq
Ironwood Pharmaceuticals Inc (IRWD) Stock Quote, History and News - Yahoo Finance
Ironwood Pharmaceuticals Inc (IRWD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6691 seconds.